Read it, then read it again , then again14 Sep 2023 09:05
This is great. Actually sit and read it.
They have responded weeks ago supported by lab tests to address the FDA concerns. Then hemo have received confirmation that this is fine.
"Further to the announcement on 10 July 2023, Hemogenyx Pharmaceuticals carefully considered the comments provided by the FDA in connection with the CH and responded in August 2023 with a detailed plan, supported by laboratory tests, to address those comments. The Company has now received confirmation from the FDA that the Company's plan satisfactorily addresses the agency's comments."